Dr Karine Mardon is the Facility Fellow for the preclinical PET/CT for the Queensland Node of the National Imaging Facility (NIF), at the Centre for Advanced Imaging, The University of Queensland. Dr Mardon obtained her PhD in radiopharmacology from University Paris XII in 1994. In 1995, she pursued postdoctoral studies at ANSTO (Sydney) in the Radiopharmaceutical Division where she gained experience in the development and characterisation of radiopharmaceuticals for SPECT and PET. She has extensive experience in in vitro and in vivo preclinical research particularly in the evaluation of drugs developed for the study of movement disorders as well as in the evaluation of radiolabelled peripheral benzodiazepine receptor ligands as markers of neurodegeneration and tumour occurrence. She has collaborated with many scientists leading the field in nuclear medicine in Australia and internationally.